Evidence‑Based Recommendations for Etiology, Risk Assessment, and Universal Neonatal Hearing Screening of Congenital Hearing Loss

Etiology Overview (American College of Medical Genetics)

• Approximately half of congenital hearing loss cases are attributable to environmental factors and the other half to genetic factors. 1
• Strength of evidence: Consensus guideline from the American College of Medical Genetics (expert opinion).

Genetic Causes (American College of Medical Genetics)

• Among genetically mediated cases, non‑syndromic forms account for ~70% of the genetic burden. 1
• Within non‑syndromic cases:
  
  • Autosomal recessive inheritance – ~77% 1
  • Autosomal dominant inheritance – ~22% 1
  • X‑linked inheritance – ~1% 1
  • Mitochondrial inheritance – <1% (can reach 10–20% in certain populations). 1
• Syndromic forms represent the remaining ~30% of genetic cases, encompassing more than 400 recognized syndromes. 1
• Strength of evidence: Consensus guideline (American College of Medical Genetics).

Environmental Causes (American College of Medical Genetics & American Family Physician)

• Major congenital infections implicated in hearing loss: rubella, cytomegalovirus, toxoplasmosis, syphilis, and herpes virus. [1][2]
• Ototoxic medications – notably aminoglycoside antibiotics. 1
• Acoustic trauma – exposure to high‑intensity sound. 1
• Strength of evidence: Consensus guideline (American College of Medical Genetics) supported by clinical review (American Family Physician).

Neonatal Risk Factors for Congenital Sensorineural Hearing Loss (American Family Physician)

• Neonatal intensive care unit (NICU) stay ≥ 2 days. 2
• Positive family history of infantile hearing loss – the most frequently observed risk factor. 2
• Syndromic associations such as Usher and Waardenburg syndromes. 2
• Maternal congenital infections during pregnancy. 2
• Craniofacial anomalies, especially malformations of the auricle or ear canal. 2
• Strength of evidence: Observational data reviewed in American Family Physician.

Limitations of Selective (Risk‑Based) Screening (American Family Physician)

• Selective screening based solely on identified risk factors detects only 50–75 % of infants with moderate‑to‑profound bilateral sensorineural hearing loss. 2
• Consequently, 25–50 % of affected children lack any identifiable risk factors. 2
• Strength of evidence: Cohort and case‑control studies summarized in American Family Physician.

Performance of Universal Two‑Stage Neonatal Hearing Screening (Siena Study) (American Family Physician)

• A two‑stage protocol (initial transient evoked otoacoustic emissions followed by diagnostic auditory brainstem response) achieved:
  
  • Sensitivity: 100 % (95 % CI 89.0–100). 2
  • Specificity: 99.3 % (95 % CI 99.2–99.4). 2
  • Area under the ROC curve: 0.997. 2
• Strength of evidence: Prospective diagnostic accuracy study.

Recommendation for Universal Neonatal Hearing Screening (American Family Physician)

• Given the substantial proportion of cases without identifiable risk factors and the high diagnostic accuracy of universal protocols, implementation of universal newborn hearing screening is strongly recommended. 2
• Strength of evidence: High‑quality diagnostic study combined with epidemiologic data.

Global Prevalence and Etiology of Congenital Profound Hearing Loss

Prevalence

• International guidelines estimate that profound pre‑lingual hearing loss occurs in 1–2 per 1,000 newborns worldwide【3】【4】【5】【6】.

Etiology Overview

• According to the same international recommendations, approximately 50 % of cases are attributable to environmental factors and the remaining 50 % to genetic causes【3】【4】【7】【8】【9】.

Genetic Causes

• Non‑syndromic (isolated) genetic hearing loss accounts for about 70 % of genetically mediated cases, while syndromic forms represent roughly 30 % and are linked to over 400 recognized syndromes【3】【4】【7】【8】【9】.
• Within non‑syndromic hereditary hearing impairment (NSHI):
  
  • ~77 % are inherited in an autosomal‑recessive pattern【3】【4】【7】【8】【9】.
  • ~22 % follow an autosomal‑dominant inheritance【3】【4】【7】【8】【9】.
  • ~1 % are X‑linked【3】【4】【7】【8】【9】.
  • Less than 1 % involve mitochondrial DNA, although prevalence can rise to 10–20 % in certain populations【3】【4】【7】【8】【9】.

Environmental Causes

These environmental contributors are identified in the international guidelines as major causes of congenital profound hearing loss【3】【4】【5】【7】【8】【6】【9】.

Risk Factors in the Neonatal Period (Italian Context)

• Neonatal intensive care unit (NICU) admission for ≥ 2 days increases the risk of congenital sensorineural hearing loss【5】【6】.
• Positive family history of childhood hearing loss is the most frequently observed risk factor【5】【6】.
• Presence of syndromes known to include hearing loss (e.g., Usher syndrome, Waardenburg syndrome) is a recognized risk【5】【6】.
• Maternal congenital infections (rubella, CMV, etc.) constitute a significant environmental risk【5】【6】.
• Craniofacial anomalies, particularly malformations of the auricle or ear canal, are associated with higher incidence【5】【6】.

Detection Rate of Universal Newborn Hearing Screening

Screening Outcomes

• Universal newborn hearing screening programs identify approximately 2–3 infants per 1,000 live births who have permanent hearing loss (defined as a threshold of ≥30 dB in at least one ear) 10